<qa>  What is the prospective multicenter, non-blinded, non-randomized safety and feasibilityThis is a prospective multi-center, non-blinded open label, non-randomized safety and feasibility study of the heterotopic implantation of the Edwards-Sapien XT or S3 valve in the inferior vena cava for the treatment of severe tricuspid regurgitation in patients who are inoperable or at a very high surgical risk for tricuspid valve replacement. 